Enriched populations of CD98− NDN, CD98− LDN and CD98+ LDN from the PB of SLE patients were isolated and the ability to produce IL‐6 in response to LPS was assessed using ELISpot (Figure 7A–C). Here, IL6 is linked to systemic lupus erythematosus.